Seres Therapeutics, Inc. financial data

Symbol
MCRB on Nasdaq
Industry
Pharmaceutical Preparations
Location
200 Sidney Street, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Seres Health, Inc. (to 5/14/2015)
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 152 % -40%
Quick Ratio 37.2 %
Debt-to-equity -816 % +83%
Return On Equity 60.8 % -96.8%
Return On Assets -8.49 % +79.1%
Operating Margin -42.2K % -36968%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 171M shares +32.1%
Common Stock, Shares, Outstanding 170M shares +32.3%
Entity Public Float 463M USD +93%
Common Stock, Value, Issued 170K USD +31.8%
Weighted Average Number of Shares Outstanding, Basic 153M shares +19%
Weighted Average Number of Shares Outstanding, Diluted 153M shares +19%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 374K USD -99.7%
Revenue from Contract with Customer, Excluding Assessed Tax 7.13M USD -95%
Research and Development Expense 86M USD -47%
General and Administrative Expense 62M USD -32.8%
Operating Income (Loss) -142M USD -6.36%
Nonoperating Income (Expense) -29.7M USD -5882%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -25.5M USD +82%
Earnings Per Share, Basic -0.22 USD/shares +79.8%
Earnings Per Share, Diluted -0.22 USD/shares +79.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 66.8M USD -60.7%
Inventory, Net 53M USD +892%
Assets, Current 72.9M USD -66%
Property, Plant and Equipment, Net 12.6M USD -46.7%
Operating Lease, Right-of-Use Asset 82.9M USD -23.3%
Other Assets, Noncurrent 465K USD -96.1%
Assets 179M USD -51.4%
Accounts Payable, Current 8.25M USD -7.86%
Employee-related Liabilities, Current 8.28M USD -38.6%
Liabilities, Current 64.8M USD -18.2%
Operating Lease, Liability, Noncurrent 85.3M USD -18.7%
Other Liabilities, Noncurrent 1.78M USD +12.9%
Liabilities 155M USD -59.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -962M USD -2.72%
Stockholders' Equity Attributable to Parent 23.9M USD
Liabilities and Equity 179M USD -51.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -35.2M USD +54%
Net Cash Provided by (Used in) Financing Activities 18.8M USD +232%
Net Cash Provided by (Used in) Investing Activities -62K USD -102%
Common Stock, Shares Authorized 360M shares +50%
Common Stock, Shares, Issued 170M shares +32.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -68.2M USD -156%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 76.7M USD -56.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.58M USD +106%
Deferred Tax Assets, Valuation Allowance 313M USD +12.8%
Deferred Tax Assets, Gross 342M USD +11.4%
Operating Lease, Liability 93.6M USD -15.8%
Payments to Acquire Property, Plant, and Equipment 62K USD -98.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -25.5M USD +82%
Lessee, Operating Lease, Liability, to be Paid 143M USD -20.1%
Property, Plant and Equipment, Gross 64.7M USD -11.6%
Operating Lease, Liability, Current 8.35M USD +32.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20M USD -7.29%
Lessee, Operating Lease, Liability, to be Paid, Year One 19.4M USD +0.03%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 49.1M USD -27.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 20.6M USD -7.1%
Deferred Tax Assets, Operating Loss Carryforwards 143M USD +7.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 13.5M USD +7.99%
Lessee, Operating Lease, Liability, to be Paid, Year Four 20.9M USD
Operating Lease, Payments 18.3M USD +29.6%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 6.02M USD -3.58%
Share-based Payment Arrangement, Expense 22.3M USD -38.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%